Navigation Links
Mediware Reports Second Quarter Fiscal 2008 Results

Teleconference Call Scheduled For 10:00am EST Today

LENEXA, Kan., Feb. 5 /PRNewswire-FirstCall/ -- Mediware Information Systems, Inc. (Nasdaq: MEDW), a provider of ClosedLoop(TM) clinical systems for blood and medication management, reported total revenue for the second quarter of fiscal year 2008 of $8,659,000 compared to $11,262,000 in the comparable quarter in fiscal year 2007. Net loss for the quarter was $337,000, or a loss of four cents per fully diluted share, compared to net income of $905,000, or eleven cents per fully diluted share in the comparable quarter of fiscal year 2007.

For the six-month period ended December 31, 2007, Mediware reported total revenue of $19,403,000 compared to $19,737,000 in the comparable period in fiscal year 2007. Net income for the six months ended December 31, 2007 was $126,000, or one cent per fully diluted share, compared to net income of $1,069,000, or thirteen cents per fully diluted share in the comparable period of fiscal year 2007. The six month results for Fiscal 2008 were hampered by a $225,000 non cash write-off of certain deferred tax assets and a cash charge of $377,000 associated with the organizational restructuring announced in July 2008.

"As anticipated, we experienced reduced revenue due to the pipeline gap following the completion of the blood management sunset program," said Kelly Mann, Mediware's president and chief executive officer. "The quarter's performance was also impacted by delays in contracting for medication management products due to the complex sales environment. However, as we continue to refresh our sales pipeline, we are encouraged that our year to date revenue is comparable to last year's record levels."

Mann Continues: "Despite our quarterly performance, I am pleased with the progress we are making with the introduction of new products, including MediREC, IMS, BloodSafe, and our extension to biologics management. We believe each of these products presents substantial opportunities for future growth."

Among the quarter's highlights:

-- Blood donor solution capabilities were strengthened through the $5.5

million acquisition of IMS.

-- Service revenues increased to $6.6 million primarily as a result of

implementation services associated with blood management sales from

previous quarters.

-- Implementation services backlog remains strong at approximately $8


-- Solidified launch plans to introduce new solutions in 2008 for

biologics management as well as a hosted medication management platform

to deliver 'on demand' capabilities to smaller acute and behavioral

health facilities.

"I believe we are building a solid foundation for future growth and I am excited about the road ahead," said Mann. "We have an enviable customer base, a very strong balance sheet, and are introducing new products and strategies to fuel future growth and expand our presence in our target markets."

Mediware will host a teleconference call today at 10:00 am Eastern Time (9:00 am Central Time) to discuss the results. There will be a question-and- answer session directly following the presentation of the results.

To participate in the teleconference, please call toll-free 888-869-1189 (direct dial 706-643-5902) five minutes before the scheduled start in order to register for the call. The conference ID is: 32798410. You may also register in advance of the call online by going to:

A replay of the call will be available after the call's completion for 5 days at 800-642-1687 (direct dial 706-645-9291). The conference ID is: 32798410.

Mediware Information Systems, Inc.

Income (loss) Statement Highlights

(in thousands, unaudited):

Three Months Ended Six Months Ended

December 31, December 31,

2007 2006 2007 2006

System Sales $2,032 $4,890 $6,222 $7,213

Services 6,627 6,372 13,181 12,524

Total Revenue 8,659 11,262 19,403 19,737

Expenses 9,469 10,103 19,381 18,542

Operating Income (loss) (810) 1,159 22 1,195

Net Income (loss) $(337) $905 $126 $1,069

Earnings (loss) Per

Share - Diluted $(0.04) $0.11 $0.01 $0.13

Mediware Information Systems, Inc.

Balance Sheet Highlights

(in thousands, unaudited):

As of

December 31,

2007 2006

Cash and Cash Equivalents $ 20,949 $ 20,974

Working Capital $ 20,706 $ 21,396

Stockholders' Equity $ 42,402 $ 40,015

About Mediware

Mediware delivers blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. Mediware's customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site at

Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2007, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.

Contact: Thomas Redington



Mark Williams

Chief Financial Officer, Mediware

913 307-1000

SOURCE Mediware Information Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Richard Greco Joins Mediware Board
2. Mediware Names Thomas K. Mann Chief Executive Officer
3. Additional Top Tier Institutions Implement Mediwares HCLL(TM) Transfusion Management Software
4. Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market
5. Mediwares Transfusion Management Software Adopted by Four Additional Tenet Hospitals
6. Texas Health and Human Services Commission Adopts Mediwares ClosedLoop(TM) Medication Management Strategy
7. Mediware Completes Acquisition of Integrated Marketing Solutions
8. Mediware to Report Second Quarter 2008 Financial Results on Tuesday, February 5th
9. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
10. Haemacure Reports Third Quarter 2007 Results
11. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert is donating half ... ” campaign. The partnership between the two groups began in 2014 with Vitalalert pledging ... , MAP International was founded in 1954 and is an international Christian-based health organization ...
(Date:11/25/2015)... ... 25, 2015 , ... On November 25, 2015, officials of Narconon Arrowhead ... the release of a new cutting edge recovery program that has been 50 years ... drug- and alcohol-addicted individuals with the purpose to free addicts from the symptoms and ...
(Date:11/25/2015)... ... 2015 , ... Smiles by Stevens is pleased to announce the ... While many patients are aware of the benefits of Botox® in the treatment of ... suffering with discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular ...
(Date:11/25/2015)... MI (PRWEB) , ... November 25, 2015 , ... In ... Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy ... medical and surgical intensive care units (totaling 30 beds) from May 2014 through October ...
(Date:11/25/2015)... ... November 25, 2015 , ... In honor ... Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary hypertension (PH) ... nominated by the public, will receive special recognition throughout 2016 as part of ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  ARKRAY USA ... continues to provide evidence demonstrating the accuracy of its ... Congress on Insulin Resistance, Diabetes and Cardiovascular Disease in ... both the Company,s GLUCOCARD ® 01 meter and ... accuracy requirements. The ability to accurately measure glucose levels ...
(Date:11/25/2015)... 25, 2015 Kitov Pharma ... KTOV), a biopharmaceutical company focused on the development of ... conditions, today announced the closing of its previously announced ... ADSs ), each representing 20 ordinary shares of the ... The ADSs and warrants were issued in a fixed ...
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015  Trovagene, ... molecular diagnostics, today announced that Chief Executive Officer Antonius ... at the 27 th Annual Piper Jaffray Healthcare ... Conference at the New York Palace Hotel in ... 2015 at 1:30 p.m. EST. Mr. Schuh will be ...
Breaking Medicine Technology: